Burak Sakar
Burak Sakar
Onkoloji Profesoru, Onkoloji Enstitusu, İstanbul Tip Fakultesi
superonline.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Anemia in oncology practice: relation to diseases and their therapies
F Tas, Y Eralp, M Basaran, B Sakar, S Alici, A Argon, G Bulutlar, ...
American journal of clinical oncology 25 (4), 371-379, 2002
1512002
Colorectal cancer in young patients: characteristics and outcome
S Alici, NF Aykan, B Sakar, G Bulutlar, E Kaytan, E Topuz
The Tohoku journal of experimental medicine 199 (2), 85-93, 2003
1102003
The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients
F Tas, Z Ustuner, G Can, Y Eralp, H Camlica, M Basaran, H Karagol, ...
Acta Oncologica 44 (2), 161-167, 2005
932005
Timing of death from tumor recurrence after curative gastrectomy for gastric cancer
B Sakar, H Karagol, M Gumus, M Basaran, E Kaytan, A Argon, Z Ustuner, ...
American journal of clinical oncology 27 (2), 205-209, 2004
912004
Skull base plasmacytoma in a patient with light chain myeloma
Z Ustuner, M Basaran, T Kiris, B Bilgic, S Sencer, B Sakar, Y Dizdar, ...
Skull base 13 (03), 167-172, 2003
502003
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study
S Saglam, D Bugra, EK Saglam, O Asoglu, E Balik, S Yamaner, ...
Journal of gastrointestinal oncology 5 (1), 9, 2014
412014
A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas
M Basaran, ES Bavbek, S Saglam, L Eralp, B Sakar, AC Atalar, B Bilgic, ...
Oncology 72 (3-4), 255-260, 2007
412007
Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix
Y Eralp, P Saip, B Sakar, S Kucucuk, A Aydiner, M Dincer, I Aslay, ...
International Journal of Gynecologic Cancer 13 (4), 2003
402003
Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
F Tas, S Karabulut, R Ciftci, F Sen, B Sakar, R Disci, D Duranyildiz
Cancer chemotherapy and pharmacology 73 (6), 1163-1171, 2014
382014
Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer
E Topuz, D Derin, G Can, E Kürklü, S Çınar, F Aykan, A Çevikbaş, R Dişçi, ...
Investigational new drugs 26 (6), 567-572, 2008
372008
Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment
A Argon, M Basaran, F Yaman, Y Dizdar, B Sakar, H Camlica, SE Bavbek, ...
Japanese Journal of Clinical Oncology 34 (11), 667-672, 2004
342004
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis
B Sakar, Z Ustuner, H Karagol, G Aksu, H Camlica, NF Aykan
American journal of clinical oncology 27 (5), 489-493, 2004
302004
Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis
G Aksu, M Fayda, B Sakar, Y Kapran
International journal of gastrointestinal cancer 34 (2), 73-77, 2003
292003
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study
E Topuz, M Basaran, P Saip, A Aydiner, A Argon, B Sakar, F Tas, K Uygun, ...
American journal of clinical oncology 25 (6), 619-624, 2002
292002
A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer
M Basaran, SE Bavbek, I Güllü, F Demirelli, B Sakar, N Tenekeci, M Altun, ...
Journal of chemotherapy 14 (2), 207-213, 2002
242002
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
NF Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, B Sakar, ...
Medical Oncology 30 (3), 679, 2013
212013
Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)
S Keskin, I Yıldız, F Sen, F Aydogan, L Kilic, M Ekenel, S Saglam, B Sakar, ...
Clinical and Translational Oncology 15 (5), 403-408, 2013
152013
Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study
ML Akin, H Uluutku, C Erenoglu, A Karadag, BM Gulluoglu, B Sakar, ...
World journal of surgery 27 (4), 395-399, 2003
142003
Prognostic significance of the metastatic lymph node ratio for survival in colon cancer.
S Tuna, B Sakar, F Aykan, H Camlica, E Topuz
Journal of BU ON.: official journal of the Balkan Union of Oncology 16 (3 …, 2011
92011
A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma
S Saglam, NF Aykan, B Sakar, M Gulluoglu, E Balik, H Karanlik
Journal of gastrointestinal oncology 2 (1), 19, 2011
92011
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20